Yue Mimi, Mason Kylie, Rowlands Shelley, Kaplan Zane, Kennedy Debra, Kidson-Gerber Giselle
Department of Haematology, Mater Health Service, Brisbane, Queensland, Australia.
School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Aust N Z J Obstet Gynaecol. 2025 Apr;65(2):183-189. doi: 10.1111/ajo.13888. Epub 2024 Sep 27.
Sickle cell disease (SCD) is a hereditary haemoglobinopathy which causes multi-organ dysfunction. Pregnancies in SCD are high risk with significant maternal and fetal morbidity and mortality, including vaso-occlusive crises, thrombosis, anaemia, placental insufficiency, fetal growth restriction, preterm birth and medication effects. High level evidence on this topic is lacking. The Australian Sickle Cell Disease Working Group has reviewed international guidelines on this topic and provide an up-to-date and structured approach to the pre-conception, antenatal, birth and post-partum management of these women. Early and comprehensive multidisciplinary care involving experienced clinicians is recommended.
镰状细胞病(SCD)是一种遗传性血红蛋白病,可导致多器官功能障碍。患有SCD的孕妇面临高风险,孕产妇和胎儿发病率及死亡率显著,包括血管闭塞性危机、血栓形成、贫血、胎盘功能不全、胎儿生长受限、早产和药物影响。关于这一主题的高水平证据尚缺。澳大利亚镰状细胞病工作组已审查了关于该主题的国际指南,并为这些女性孕前、产前、分娩和产后管理提供了最新的结构化方法。建议由经验丰富的临床医生进行早期和全面的多学科护理。